Comparison of Telavancin & Vancomycin for Complicated Skin & Skin

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus — ATLAS2

Staphylococcal Skin Infection Clinical Trial

Official title:
A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus

See also
Status	Clinical Trial	Phase
Completed	`NCT00352612` - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections	Phase 4
Completed	`NCT00091819` - Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus	Phase 3
Completed	`NCT00442832` - TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection	Phase 2
Completed	`NCT01814371` - Individualized vs. Household MRSA Decolonization	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Phase 4

Completed

NCT00091819 - Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Phase 3

Completed

NCT00442832 - TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Phase 2

Completed

NCT01814371 - Individualized vs. Household MRSA Decolonization

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00107978
Study type	Interventional
Source	Cumberland Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	February 2005
Completion date	May 2006

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus — ATLAS2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms